Predictive oximetry model and method

• US 20090030296A1
• Filed: 07/24/2007
• Published: 01/29/2009
• Est. Priority Date: 07/24/2007
• Status: Abandoned Application

• Current Assignee: Woolsthorpe, LLC
• Original Assignee: Woolsthorpe, LLC
• Inventors: Sterling, Bernhard B.
• Application Number:
  US11/881,103
• Publication Number:
  US 20090030296A1
• Time in Patent Office: Days
• US Class Current: 600/323
• CPC Class Codes: A61B 5/14551 for measuring blood gases

Abstract

The invention comprises a method for determining oxygen saturation in a subject, comprising the steps of compiling a data base of measured spectral data that includes pulsatile AC and non-pulsatile DC components, and spectral values of oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb); determining absorbed pulsatile components and non-pulsatile components as a function of the oxyHb and deoxyHb values; determining total pulsatile and non-pulsatile optical density as a function of the absorbed pulsatile and non-pulsatile components; determining a mathematical relationship between at least one pulsatile AC parameter and at least one non-pulsatile DC parameter; and estimating oxygen saturation based on the mathematical relationship.

Claims

4-1. The method of claim 1, wherein said mathematical relationship comprises a ratio of logarithms (R), said ratio of logarithms (R) being determined according to the following equation

R=(log (T_p@W1/log T_n,p@W1))/log (T_p@W2/log T_{n,p @W2}))

wherein, T_p represents said total pulsatile transmittance equivalent value, T_n,p represents said total non-pulsatile transmittance equivalent value, W1 represents a first wavelength and W2 represents a second wavelength.

6-7. -7. (canceled)

7. A method of determining oxygen saturation in a subject, comprising the steps of:

compiling a data base of measured spectral data characterizing the transmission of light through a tissue of interest in the subject, said spectral data including pulsatile AC and non-pulsatile DC components of said transmitted light, and spectral values of oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb);

determining light scattering intensity (I) of said AC and DC components;

determining absorbed pulsatile components and non-pulsatile components as a function of said oxyHb and deoxyHb values;

determining total pulsatile optical density as a function of said absorbed pulsatile components and said AC component scattered light intensity;

determining total non-pulsatile optical density as a function of said absorbed non-pulsatile components and said DC component scattered light intensity;

determining at least one total pulsatile transmittance equivalent value as a function of said total pulsatile optical density;

determining at least one total non-pulsatile transmittance equivalent value as a function of said total non-pulsatile optical density;

determining a ratio of logarithms as a function of said pulsatile and non-pulsatile transmittance equivalent values; and

estimating oxygen saturation based on said ratio of logarithms.

8. The method of claim 7, wherein said light scattering intensity (I) of said AC and DC components is determined according to the following equation

I=s/(γ

^exp)

wherein, γ

represents the wavelength and s represents an adjustment factor.

9. The method of claim 8, wherein said adjustment factor (s) is adjusted to provide between approximately 60% and 80% of the total DC component at a wavelength equal to approximately 805 nm when the total DC component reaches a total optical density level of approximately 1.5.

10. The method of claim 7, wherein said total pulsatile optical density (OD_t,p) is determined according to the following equation

OD_t,p=(a*OD_a,p)+(b*OD_v,p)+(c*OD_o,p)+(d*I_s,p)

wherein, a represents a fractional coefficient for arterialized, fully oxygenated pulsatile optical density, b represents a fractional coefficient for venous pulsatile optical density, c represents a fractional coefficient for pulsatile optical density of other hemoglobin (Hb) components, d represents a fractional coefficient for pulsatile scattering intensity, I_s,p represents pulsatile scattering intensity, OD_a,p represents arterialized, fully oxygenated pulsatile optical density, OD_v,p represents venous, fully oxygenated pulsatile optical density, and OD_o,p represents pulsatile optical density of other Hb components.

11. The method of claim 7, wherein said total non-pulsatile optical density (OD_t,np) is determined according to the following equation

OD_t,np=(e*OD_a,np)+(f*OD_v,np)+(g*OD_o,np)+(h*I_s,np)

wherein, e represents a fractional coefficient for arterialized, fully oxygenated non-pulsatile optical density, f represents a fractional coefficient for venous, fully oxygenated non-pulsatile optical density, g represents a fractional coefficient for non-pulsatile optical density of other hemoglobin (Hb) components, h represents a fractional coefficient for non-pulsatile scattering intensity, I_s,np represents non-pulsatile scattering intensity, OD_a,np represents arterialized, fully oxygenated non-pulsatile optical density, OD_v,np represents venous, fully oxygenated non-pulsatile optical density, and OD_o,np represents non-pulsatile optical density of other hemoglobin (Hb) components.

12. The method of claim 7, wherein said total pulsatile transmittance equivalent value (T_p) is determined according to the following equation

T_p= 1/10^ODt,p

13. The method of claim 7, wherein said total non-pulsatile transmittance equivalent value (T_n,p) is determined according to the following equation

T_n,p= 1/10^ODt,np

14. The method of claim 7, wherein said ratio of logarithms (R) is determined according to the following equation

R=(log(T_p@W1/log T_n,p@W1))/log(T_p@W2/log T_n,p@W2))

wherein, T_p represents said total pulsatile transmittance equivalent value, T_n,p represents said total non-pulsatile transmittance equivalent value, W1 represents a first wavelength and W2 represents a second wavelength.

9-12. -12. (canceled)

14-22. -22. (canceled)

15. A method of determining oxygen saturation in a subject, comprising the steps of:

providing a pulse oximetry system, said pulse oximetry system including a tissue probe having a radiation emitter that is adapted to transmit light having a first wavelength through a tissue of interest and a radiation detector that is adapted to receive said transmitted light after transmission through said tissue;

measuring said transmission of light through said tissue of interest in the subject with said pulse oximetry system;

compiling a data base of measured spectral data characterizing said transmission of light through said tissue of interest, said spectral data including pulsatile AC and non-pulsatile DC components of said transmitted light, and spectral values of oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb);

determining light scattering intensity of said AC and DC components;

determining absorbed pulsatile components and non-pulsatile components as a function of said oxyHb and deoxyHb values;

determining total pulsatile optical density as a function of said absorbed pulsatile components and said AC component scattered light intensity;

determining total non-pulsatile optical density as a function of said absorbed non-pulsatile components and said DC component scattered light intensity;

determining at least one total pulsatile transmittance equivalent value as a function of said total pulsatile optical density;

determining at least one total non-pulsatile transmittance equivalent value as a function of said total non-pulsatile optical density;

determining a ratio of logarithms as a function of said pulsatile and non-pulsatile transmittance equivalent values; and

estimating oxygen saturation based on said ratio of logarithms.

16. The method of claim 15, wherein said light scattering intensity of said AC and DC components is determined according to the following equation

I=s/(λ

^exp)

wherein, λ

represents the wavength and s represents an adjustment factor.

17. The method of claim 15, wherein said total pulsatile optical density (OD_t,p) is determined according to the following equation

OD_t,p=(a*OD_a,p)+(b*OD_v,p)+(c*OD_o,p)+(d*I_s,p)

wherein, a represents a fractional coefficient for arterialized, fully oxygenated pulsatile optical density, b represents a fractional coefficient for venous pulsatile optical density, c represents a fractional coefficient for pulsatile optical density of other hemoglobin (Hb) components, d represents a fractional coefficient for pulsatile scattering intensity, I_s,p represents pulsatile scattering intensity, OD_a,p represents arterialized, fully oxygenated pulsatile optical density, OD_v,p represents venous, fully oxygenated pulsatile optical density, and OD_o,p represents pulsatile optical density of other Hb components.

18. The method of claim 15, wherein said total non-pulsatile optical density (OD_t,np) is determined according to the following equation

OD_t,np=(e*OD_a,np)+(f*OD_v,np)+(g*OD_o,np)+(h*I_s,np)

wherein, e represents a fractional coefficient for arterialized, fully oxygenated non-pulsatile optical density, f represents a fractional coefficient for venous, fully oxygenated non-pulsatile optical density, g represents a fractional coefficient for non-pulsatile optical density of other hemoglobin (Hb) components, h represents a fractional coefficient for non-pulsatile scattering intensity, I_s,np represents non-pulsatile scattering intensity, OD_a,np represents arterialized, fully oxygenated non-pulsatile optical density, OD_v,np represents venous, fully oxygenated non-pulsatile optical density, and OD_o,np represents non-pulsatile optical density of other hemoglobin (Hb) components.

19. The method of claim 15, wherein said total pulsatile and non-pulsatile transmittance equivalent values are determined at a plurality of wavelengths.

20. The method of claim 15, wherein said total pulsatile transmittance equivalent value (T_p) is determined according to the following equation

T_p= 1/10^ODt,p

21. The method of claim 15, wherein said total non-pulsatile transmittance equivalent value (T_n,p) is determined according to the following equation

T_n,p= 1/10^ODt,np

22. The method of claim 15, wherein said ratio of logarithms (R) is determined according to the following equation

R=(log (T_p@W1/log T_{n,p@W1))/(log (Tp@W2}/log T_n,p@W2))

wherein, T_p represents said total pulsatile transmittance equivalent value, T_n,p represents said total non-pulsatile transmittance equivalent value, W1 represents a first wavelength and W2 represents a second wavelength.

23. A method of calibrating a pulse oximetery system, comprising the steps of:

providing a pulse oximetry system, said pulse oximetry system including a tissue probe having a radiation emitter that is adapted to transmit light having a first wavelength through a tissue of interest and a radiation detector that is adapted to receive said transmitted light after transmission through said tissue;

measuring said transmission of light through said tissue of interest in the subject with said pulse oximetry system;

compiling a data base of measured spectral data characterizing the transmission of light through a tissue of interest in the subject, said spectral data including pulsatile AC and non-pulsatile DC components of said transmitted light, and spectral values of oxyhemoglobin (oxyHb) and deoxyhemoglobin (deoxyHb);

determining light scattering intensity of said AC and DC components;

determining absorbed pulsatile components and non-pulsatile components as a function of said oxyHb and deoxyHb values;

determining a corrected ratio of logarithms based on said absorbed pulsatile and non-pulsatile components, and said AC and DC component scattered light intensities, said corrected ratio of logarithms representing oxygen saturation in a subject.

27-30. -30. (canceled)

32-36. -36. (canceled)

40-41. -41. (canceled)

44-45. -45. (canceled)

47-50. -50. (canceled)

52-55. -55. (canceled)

60-61. -61. (canceled)